Company: ARTL
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001640334-25-001375
Chunk: 0

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-07
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On August 1, 2025 (the “ Effective Date”), Artelo Biosciences, Inc. (the “ Company”) entered into a Consulting Agreement (the “ Consulting Agreement”) with ABK Labs, Inc., a Delaware corporation (“ ABK Labs”). Pursuant to the Consulting Agreement, ABK Labs will provide strategic advisory services to the Company related to the development, implementation, and communication of the Company’s digital asset strategy, as well as business development, financial and technical advisory, investor relations, and other related support services. The term of the Consulting Agreement is four years from the Effective Date, with automatic renewal for additional 12-month periods unless terminated by either party upon 30 days’ prior written notice.

As consideration for the services to be provided under the Consulting Agreement, the Company has agreed, subject to approval by the Company’s board of directors, to issue to ABK Labs warrants (the “ ABK Labs Warrants”) to purchase up to 55,000 shares of the Company’s common stock, par value $0.001 per share, at an exercise price of $10.20 per share.

The ABK Labs Warrants will vest and become exercisable in tranches, subject to ABK Labs’ continued service and the achievement of certain performance milestones, including the Company’s market capitalization reaching specified thresholds. The ABK Labs Warrants provide for acceleration of vesting upon the achievement of certain milestones or in connection with certain termination or change in control events, as described in the ABK Labs Warrants. Any unvested portion of the ABK Labs Warrants will be forfeited upon termination of service, subject to certain exceptions. The ABK Labs Warrants are exercisable for cash or on a cashless basis, and are subject to adjustment in the event of stock splits, combinations, mergers, or similar events. The ABK Labs Warrants and the shares issuable upon exercise thereof have not been registered under the Securities Act of 1933, as amended (the “ Securities Act’), and may not be transferred or exercised except pursuant to an effective registration statement or an available exemption from registration. The ABK Labs Warrants will be issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and in reliance on similar exemptions under applicable state laws.

The Consulting Agreement contains customary confidentiality, indemnification, and termination provisions. ABK Labs will serve as an independent contractor.

The foregoing